No images? Click here
Samsung Electronics acquires Oxford Semantic Technologies
An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.
Oxford University Innovation announces new Chief Executive
Oxford University Innovation announces the permanent appointment of CEO Dr Mairi Gibbs.
Oxford tech transfer partnership pioneers new women's healthcare company
Amber Therapeutics, a start-up involving the University of Oxford, has just completed a $100 million Series A funding round from healthcare and technology investors in the US and UK to develop its treatment for mixed urinary incontinence.
BIOTECH
Yellowstone Biosciences launches to advance cutting edge cancer therapies
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the University of Oxford.
OUI's Spinout Spotlights continues with our latest video with Holly Reeve, CEO and co-founder of HydRegen.
MEDTECH
New Oxford spinout company Kodiform Therapeutics launches to tackle cancer
Kodiform Therapeutics, a new joint spinout company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises.
OrganOx open state-of-the-art research HQ in Oxford
OrganOx Ltd, a leading medical technology company, with a focus on the therapeutic applications of isolated organ perfusion, has opened an 18,000 sq ft global headquarter in Oxford.
Oxford spinout Brainomix has partnered with Boehringer Ingelheim to use AI imaging software to improve the diagnosis and treatment of fibrosing lung disease in the US, aiming to help patients get care sooner and improve their outcomes.
Clinical Outcomes Assessments
Enhancing clinical trials: The vital role of Clinical Outcome Assessments
Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.
Spotlight on consulting services - linguistics
A pioneering measurement system to assess communication patterns has been developed through a collaborative consultancy project between an Oxford linguistics expert and a leading global strategic communications consultancy.
News from investments
Software spinout founders and investors now have a valuable resource to expedite their scaling efforts with the launch of the latest USIT guide.
Oxford University Innovation welcomed more than 50 investors for the first ever Deep Tech showcase day in Oxford to connect with spinout companies seeking investment and partnership.
Oxford Ionics and the race towards quantum computers
Dr Chris Ballance, co-founder and CEO of quantum computing spinout Oxford Ionics, talks about his experience growing this pioneering company.
Become an OIS member to join our annual networking event in November: Impact at Oxford 2024
Inspiring the next generation
Introducing the recipients of 2024 Jamie Ferguson Innovation Awards
The third year of the Jamie Awards featured ideas such as cleaner hydrogen use in chemical production, an agrochemical for improving crop resilience to floods, advancements in materials for safer and more efficient batteries, and the development of new medical treatments using 3D printing.
StEP Ignite, our month-long student entrepreneurship programme, is underway at OUI throughout July. Nine different teams formed from a cohort of 27 students have joined our Start-up Incubator to work on their business ideas – with projects ranging from a non-invasive malaria test and a cybersecurity risk management platform, to VR-based medical equipment training and a digital marketplace for African fashion suppliers.
Technologies to License
Adult-phenotype dendritic cells grown from induced pluripotent stem cells
for immunotherapy
Oxford researchers have developed a method to produce dendritic cells from iPS cells that display a mature ‘adult phenotype’, substantially increasing their potential effectiveness in immunotherapy.
A method for diagnosing diseases like Parkinson’s or Dementia by comparing ganglioside fingerprints from patient samples. It also classifies subjects into subgroups for patient stratification in trials.
A method for generating therapeutic nitric oxide (NO) from an amine-functionalised graphene coating, applicable to medical devices like stents.
Block copolymer electrolytes for solid-state batteries
Oxford scientists have developed innovative block copolymer electrolytes that deliver exceptional performance for solid-state battery composite cathodes.
Job Opportunities
